Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting

Infection Control and Hospital Epidemiology

Volumn 36, Issue 3, 2015, Pages 280-286

  Scardina, T ^a   Labuszewski, L ^a   Pacheco, S M ^a,b   Adams, W ^c   Schreckenberger, P ^a   Johnson, S ^a,b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b HINES VA HOSPITAL   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CEFTRIAXONE; CREATININE; METRONIDAZOLE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BACTERIAL STRAIN; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CLOSTRIDIUM DIFFICILE NAP1 STRAIN; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FECES ANALYSIS; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MORTALITY; NONHUMAN; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; CASE CONTROL STUDY; CLASSIFICATION; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR TYPING; MULTIVARIATE ANALYSIS; PEPTOCLOSTRIDIUM DIFFICILE; RETROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR TYPING; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84923323390     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1017/ice.2014.45     Document Type: Article

References (25)

1. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353:2433-2441
2. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442-2449
3. O’Connor JR, Johnson S, Gerding DN. Clostridium difficle infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 2009;136:1913-1924
4. Vardakas KZ, Konstantelias AA, Loizidis G, Rafailidis PI, Falagas ME. Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis. Int J Infect Dis 2012;16:e768-773
5. Miller M, Gravel, Mulvey M, et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010;50:194-201
6. Walker AS, Eyre DW, Wyllie DH, et al. Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis 2013;56:1589-1600
7. See I, Mu Y, Cohen J, et al. NAP1 Strain type predicts outcomes from Clostridium difficile infection. Clin Infect Dis 2014
8. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431-455
9. Zar FA, Bakkanagari SR, Moorthi KM, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007;45:302-307
10. Debast SB, Vaessen N, Choudry A, Wiegers-Ligtvoet EAJ, van den Berg RJ, Kuijper EJ. Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors. Clin Microbiol Infect 2009;15:427-434
11. Goorhuis A, Debast SB, Dutilh JC, et al. Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital. Clin Infect Dis 2011;53: 860-869
12. Cloud J, Noddin L, Pressman A, Hu M, Kelly C. Clostridium difficile strain NAP-1 is not associated with severe disease in a non-epidemic setting. Clin Gastroenterol Hepatol 2009;7:868-873
13. Wilson V, Cheek L, Satta G, et al. Predicators of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis 2010;50:e77-e81
14. Limbago BM, Long CM, Thompson AD, et al. Clostridium difficile strains from community-associated infections. J Clin Microbiol 2009;47:3004-3007
15. Black SR, Weaver KN, Jones RC, et al. Clostridium difficile outbreak strain BI is highly endemic in Chicago area hospitals. Infect Control Hosp Epidemiol 2011;32:897-902
16. Labbé AC, Poirier L, MacCannell D, et al. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP/027 strain. Antimicrob Agents Chemother 2008;52:3180-3187
17. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and non-epidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 2007;45:992-998
18. Morgan OW, Rodrigues B, Elston T, et al. Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. PLoS ONE 2008;3(3):e1812
19. Belmares J, Gerding DN, Tillotson G, Johnson S. Measuring the severity of Clostridium difficile infection: implications for management and drug development. Expert Rev Anti Infect Ther 2008;6:897-908
20. Boone JH, Goodykoontz M, Rhodes SJ, et al. Clostridium difficile prevalence rates in a large healthcare system stratified according to patient population, age, gender, and specimen consistency. Eur J Clin Microbiol Infect Dis 2012;31:1551-1559
21. Sirard S, Valiquette L, Fortier LC. Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes. J Clin Microbiol 2011;49:4040-4046
22. Petrella LA, Sambol SP, Cheknis A, et al. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis 2012;55:351-357
23. Marsh JW, Arora R, Schlackman JL, Shutt KA, Curry SR, Harrison LH. Association of relapse of Clostridium difficile disease with BI/NAP1/027. J Clin Microbiol 2012;50:4078-4082
24. Walk ST, Micic D, Jain R, et al. Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis 2012;55:1661-1668
25. Abou Chakra CN, Pepin J, Sirard S, Valiquette L. Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review. PLoS One 2014;9:e98400.